abstract |
The present invention provides a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion or a pharmaceutically acceptable salt thereof, at least one monovalent counterion or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent . The present invention also relates to a method of inhibiting cancer cell growth comprising administering a pharmaceutical composition as described herein. |